Glenmark begins phase 3 of clinical trials on antiviral Favipiravir for COVID-19 patients in India

May 12, 2020

Mumbai (Maharashtra) [India], May 12 : Glenmark Pharmaceuticals has initiated phase three of clinical trials in India on antiviral tablet Favipiravir, becoming the first...

Converge Biotech announces the launch of Vergiflu (Favipiravir 200 mg) in India to treat mild to moderate Covid-19

Aug 04, 2020

Hyderabad (Telangana) [India] Aug 4 (ANI/BusinessWire India): Converge Biotech, a leading healthcare company based at Hyderabad, today announces the launch of generic Favipiravir tablet...

Sun Pharma launches Favipiravir in India for Rs 35 per tablet

Aug 04, 2020

Mumbai (Maharashtra) [India], Aug 4 : Sun Pharmaceutical Industries said on Tuesday it has launched Favipiravir (200 mg) in India under the brand FluGuard...

'Govt still not satisfied with the efficacy of antiviral drugs Remdesivir, Favipiravir in fighting COVID-19'

May 15, 2020

New Delhi [India], May 15 : The Union Health Ministry is still not satisfied with the efficacy of two antiviral drugs--Remdesivir and Favipiravir--for the...

Glenmark to start new phase 3 clinical trial for hospitalised patients of moderate COVID-19

May 26, 2020

Mumbai (Maharashtra) [India], May 26 : Glenmark Pharmaceuticals on Tuesday announced a new randomised, open-label study to test the combined efficacy of two antiviral...

Lupin launches Favipiravir in India for COVID treatment at Rs 49 per tablet

Aug 05, 2020

Mumbai (Maharashtra) [India], Aug 5 : Pharma major Lupin Ltd on Wednesday announced the launch of Favipiravir in India under the brand name Covihalt...